CHARLES SCHWAB INVESTMENT MANAGEMENT INC - CELLDEX THERAPEUTICS INC NEW ownership

CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 141 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2016. The put-call ratio across all filers is 1.05 and the average weighting 0.0%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q1 2018$1,338,000
-28.8%
573,947
-13.2%
0.00%0.0%
Q4 2017$1,879,000
+15.0%
661,295
+15.8%
0.00%0.0%
Q3 2017$1,634,000
+10.3%
571,107
-4.8%
0.00%0.0%
Q2 2017$1,482,000
-19.5%
599,878
+17.6%
0.00%
-50.0%
Q1 2017$1,842,000
+25.5%
510,036
+23.1%
0.00%0.0%
Q4 2016$1,468,000
-7.8%
414,492
+5.1%
0.00%0.0%
Q3 2016$1,593,000
+7.0%
394,247
+16.2%
0.00%0.0%
Q2 2016$1,489,000
+23.2%
339,154
+6.1%
0.00%0.0%
Q1 2016$1,209,000
-76.5%
319,736
-2.7%
0.00%
-71.4%
Q4 2015$5,155,000
+57.3%
328,738
+5.7%
0.01%
+40.0%
Q3 2015$3,278,000
-57.4%
310,938
+2.0%
0.01%
-54.5%
Q2 2015$7,689,000
-1.0%
304,858
+9.4%
0.01%0.0%
Q1 2015$7,770,000
+64.6%
278,769
+7.8%
0.01%
+57.1%
Q4 2014$4,720,000
+49.4%
258,603
+6.1%
0.01%
+40.0%
Q3 2014$3,160,000
-17.6%
243,767
+3.7%
0.01%
-16.7%
Q2 2014$3,835,000
-8.0%
234,980
-0.4%
0.01%
-14.3%
Q1 2014$4,169,000
-23.6%
235,908
+4.6%
0.01%
-30.0%
Q4 2013$5,459,000
-27.4%
225,456
+13.4%
0.01%
-33.3%
Q3 2013$7,518,000
+141.0%
198,728
+4.3%
0.02%
+114.3%
Q2 2013$3,119,000190,6200.01%
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q3 2016
NameSharesValueWeighting ↓
TSP Capital Management Group, LLC 813,273$3,286,0001.66%
RTW INVESTMENTS, LP 1,243,164$5,022,0001.52%
Marcus Capital, LLC 112,200$453,0000.44%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 996,178$4,024,0000.29%
Benchmark Capital Advisors 67,000$271,0000.20%
SUFFOLK CAPITAL MANAGEMENT LLC 360,299$1,456,0000.20%
COLUMBIA WANGER ASSET MANAGEMENT LLC 2,907,523$11,746,0000.15%
Virtus ETF Advisers LLC 59,537$241,0000.12%
Bellevue Group AG 160,000$646,0000.12%
PDT Partners, LLC 428,300$1,730,0000.10%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders